Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Shares Outstanding (Diluted Average) (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) changed 0.07% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, changed 0.07%, and an annual FY2024 reading of $1.5 million, up 0.86% over the prior year.
  • Shares Outstanding (Diluted Average) was $1.5 million for Q3 2025 at Xenetic Biosciences, roughly flat from $1.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $1.5 million in Q1 2025 and bottomed at $1.5 million in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $1.5 million, with a median of $1.5 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) rose 1.58% in 2024, then grew 0.07% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $1.5 million in 2023, then grew by 0.86% to $1.5 million in 2024, then increased by 0.05% to $1.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for XBIO at $1.5 million in Q3 2025, $1.5 million in Q2 2025, and $1.5 million in Q1 2025.